Concepedia

Christopher H. So

CH

10

Publications

1.4K

Citations

10

H-Index

2004

Active since

Affiliations

University of Toronto(Current)

Centre for Addiction and Mental Health

Thomas Jefferson University

Christopher H. So is an author at University of Toronto specializing in medicine, pharmacology, and neuropharmacology.

ORCID

Top concepts

Publications per year

2004–2019

10

Publications

10

D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G <sub>q</sub> /11 in the striatum

Asim J. Rashid, Christopher H. So, Michael M. C. Kong et al. · Proceedings of the National Academy of Sciences · 2006 · 483 citations · Full text

, , +20

Dopamine D1 and D2 Receptor Co-activation Generates a Novel Phospholipase C-mediated Calcium Signal

Samuel P. Lee, Christopher H. So, Asim J. Rashid et al. · Journal of Biological Chemistry · 2004 · 451 citations · Full text

, , +17

D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor

Christopher H. So, George Varghese, Kevin J. Curley et al. · Molecular Pharmacology · 2005 · 112 citations

Calcium Signaling by Dopamine D5 Receptor and D5-D2 Receptor Hetero-Oligomers Occurs by a Mechanism Distinct from That for Dopamine D1-D2 Receptor Hetero-Oligomers

Christopher H. So, Vaneeta Verma, Mohammad Alijaniaram et al. · Molecular Pharmacology · 2009 · 107 citations · Full text

Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells

Jason R. Juhasz, Ahmed Hasbi, Asim J. Rashid et al. · European Journal of Pharmacology · 2008 · 59 citations

, , +12

Rows per page

1–5 of 10